Abstract:BackgroundHepatocellular carcinoma (HCC) is the most common malignant tumor of the liver. Non-alcoholic fatty liver disease (NAFLD) is a frequent chronic liver disorder in developed countries. NAFLD can progress through the more severe non alcoholic steatohepatitis (NASH), cirrhosis and, lastly, HCC. Genetic and epigenetic alterations of coding genes as well as deregulation of microRNAs (miRNAs) activity play a role in HCC development. In this study, the C57BL/6J mouse model was long term high-fat (HF) or low-fat (LF) diet fed, in order to analyze molecular mechanisms responsible for the hepatic damage progression.MethodsMice were HF or LF diet fed for different time points, then plasma and hepatic tissues were collected. Histological and clinical chemistry assays were performed to assess the progression of liver disease. MicroRNAs’ differential expression was evaluated on pooled RNAs from tissues, and some miRNAs showing dysregulation were further analyzed at the individual level.ResultsCholesterol, low and high density lipoproteins, triglycerides and alanine aminotransferase increase was detected in HF mice. Gross anatomical examination revealed hepatomegaly in HF livers, and histological analysis highlighted different degrees and levels of steatosis, inflammatory infiltrate and fibrosis in HF and LF animals, demonstrating the progression from NAFLD through NASH. Macroscopic nodules, showing typical neoplastic features, were observed in 20 % of HF diet fed mice. Fifteen miRNAs differentially expressed in HF with respect to LF hepatic tissues during the progression of liver damage, and in tumors with respect to HF non tumor liver specimens were identified. Among them, miR-340-5p, miR-484, miR-574-3p, miR-720, whose expression was never described in NAFLD, NASH and HCC tissues, and miR-125a-5p and miR-182, which showed early and significant dysregulation in the sequential hepatic damage process.ConclusionsIn this study, fifteen microRNAs which were modulated in hepatic tissues and in tumors during the transition NAFLD-NASH-HCC are reported. Besides some already described, new and early dysregulated miRNAs were identified. Functional analyses are needed to validate the results here obtained, and to better define the role of these molecules in the progression of the hepatic disease.

MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway

Aberrant Hepatic Microrna Expression in Nonalcoholic Fatty Liver Disease

Uric Acid Induced Hepatocytes Lipid Accumulation Through Regulation of Mir-149-5p/fgf21 Axis

miR-21: A therapeutic target for delaying severe liver disease and hepatocellular carcinoma in high-fat-diet-fed mice

Abstract 5689: miR-21: A therapeutic target that delays severe liver disease and hepatocellular carcinoma under high-fat-diet conditions

MicroRNA-21 Contributes to Liver Regeneration by Targeting PTEN

Role and Mechanisms of Action of Microrna‑21 As Regards the Regulation of the WNT/β‑catenin Signaling Pathway in the Pathogenesis of Non‑alcoholic Fatty Liver Disease.

MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes

MicroRNA-21 Suppresses PTEN and Hsulf-1 Expression and Promotes Hepatocellular Carcinoma Progression Through AKT/ERK Pathways.

Anti–miR-21 Suppresses Hepatocellular Carcinoma Growth Via Broad Transcriptional Network Deregulation

Mutation of Mir-21 Targets Endogenous Lipoprotein Receptor-Related Protein 6 and Nonalcoholic Fatty Liver Disease.

Investigation of the clinical significance and molecular mechanism of miR-21-5p in hepatocellular carcinoma: A systematic review based on 24 studies and bioinformatics investigation.

Mir-149 Controls Non-Alcoholic Fatty Liver by Targeting Fgf-21

Silencing of Functional P53 Attenuates NAFLD by Promoting HMGB1-related Autophagy Induction

MicroRNA-21 Promotes Hepatocellular Carcinoma HepG2 Cell Proliferation Through Repression of Mitogen-Activated Protein Kinase-Kinase 3

Lipotoxic Effect of P21 on Free Fatty Acid-Induced Steatosis in L02 Cells

The Critical Role of microRNA-21 in Non-alcoholic Fatty Liver Disease Pathogenesis

Significance of Serum Microrna-21 in Diagnosis of Hepatocellular Carcinoma (HCC): Clinical Analyses of Patients and an HCC Rat Model.

Critical Role of microRNA-21 in the Pathogenesis of Liver Diseases

MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice

Knockout of microRNA-21 attenuates alcoholic hepatitis through the VHL/NF-κB signaling pathway in hepatic stellate cells.